Thromboangiitis obliterans and endothelial function

European Journal of Clinical Investigation

Volumn 40, Issue 6, 2010, Pages 518-526

  Azizi, Michel ^a,b,c   Boutouyrie, Pierre ^a,b,d   Bura Rivière, Alessandra ^e   Peyrard, Séverine ^b,c   Laurent, Stéphane ^a,b,d   Fiessinger, Jean Noël ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Buerger disease; Vascular remodelling; Vasoconstriction

Indexed keywords

GLYCERYL TRINITRATE;

ADULT; ARTERIAL STIFFNESS; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; BUERGER DISEASE; CAROTID ARTERY PULSE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FEMORAL ARTERY; HEATING; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHEAR STRESS; VASOCONSTRICTION; VASODILATATION;

ADULT; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HOT TEMPERATURE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; PULSATILE FLOW; SKIN; THROMBOANGIITIS OBLITERANS; VASODILATION; VASODILATOR AGENTS;

EID: 77952599872     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02294.x     Document Type: Article

References (36)

1. Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med 2000 343: 864 869.
2. Adar R, Papa MZ, Halpern Z, Mozes M, Shoshan S, Sofer B et al. Cellular sensitivity to collagen in thromboangiitis obliterans. N Engl J Med 1983 308: 1113 1116.
3. Eichhorn J, Sima D, Lindschau C, Turowski A, Schmidt H, Schneider W et al. Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998 315: 17 23.
4. Czarnacki M, Gacka M, Adamiec R. A role of endothelin 1 in the pathogenesis of thromboangiitis obliterans (initital news). Przegl Lek 2004 61: 1346 1350.
5. Lee T, Seo JW, Sumpio BE, Kim SJ. Immunobiologic analysis of arterial tissue in Buerger's disease. Eur J Vasc Endovasc Surg 2003 25: 451 457.
6. Slavov ES, Stanilova SA, Petkov DP, Dobreva ZG. Cytokine production in thromboangiitis obliterans patients: new evidence for an immune-mediated inflammatory disorder. Clin Exp Rheumatol 2005 23: 219 226.
7. Makita S, Nakamura M, Murakami H, Komoda K, Kawazoe K, Hiramori K. Impaired endothelium-dependent vasorelaxation in peripheral vasculature of patients with thromboangiitis obliterans (Buerger's disease). Circulation 1996 94: II211 5.
8. Joras M, Poredos P, Fras Z. Endothelial dysfunction in Buerger's disease and its relation to markers of inflammation. Eur J Clin Invest 2006 36: 376 382.
9. Kimura M, Ueda K, Goto C, Jitsuiki D, Nishioka K, Umemura T et al. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2007 27: 1403 1410.
10. Seal JB, Gewertz BL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 2005 19: 572 584.
11. Azizi M, Boutouyrie P, Bissery A, Agharazii M, Verbeke F, Stern N et al. Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humans. J Clin Invest 2005 115: 780 787.
12. Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger's disease. Eur J Vasc Endovasc Surg 1996 11: 335 339.
13. Joannides R, Bizet-Nafeh C, Costentin A, Iacob M, Derumeaux G, Cribier A et al. Chronic ACE inhibition enhances the endothelial control of arterial mechanics and flow-dependent vasodilatation in heart failure. Hypertension 2001 38: 1446 1450.
14. Bellien J, Iacob M, Gutierrez L, Isabelle M, Lahary A, Thuillez C et al. Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation. Hypertension 2006 48: 1088 1094.
15. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999 100: 1387 1393.
16. Bussy C, Boutouyrie P, Lacolley P, Challande P, Laurent S. Increased stiffness of the carotid arterial material in essential hypertension. Hypertension 2000 35: 1049 1054.
17. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001 37: 1236 1241.
18. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002 39: 735 738.
19. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006 27: 2588 2605.
20. Joannides R, Costentin A, Iacob M, Compagnon P, Lahary A, Thuillez C. Influence of vascular dimension on gender difference in flow-dependent dilatation of peripheral conduit arteries. Am J Physiol Heart Circ Physiol 2002 282: H1262 9.
21. Hoeks AP, Willekes C, Boutouyrie P, Brands PJ, Willigers JM, Reneman RS. Automated detection of local artery wall thickness based on M-line signal processing. Ultrasound Med Biol 1997 23: 1017 1023.
22. Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M. Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas 1991 12: 39 54.
23. Savage MV, Brengelmann GL. Reproducibility of the vascular response to heating in human skin. J Appl Physiol 1994 76: 1759 1763.
24. Briet M, Collin C, Laurent S, Tan A, Azizi M, Agharazii M et al. Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension 2007 50: 970 976.
25. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P et al. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 2001 88: 145 151.
26. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 2008 51: 1959 1964.
27. Bots ML, Westerink J, Rabelink TJ, de Koning EJ. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. Eur Heart J 2005 26: 363 368.
28. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr. et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004 109: 613 619.
29. Vita JA, Keaney JF Jr., Larson MG, Keyes MJ, Massaro JM, Lipinska I et al. Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation 2004 110: 3604 3609.
30. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993 88: 2149 2155.
31. Lambert J, Stehouwer CD. Modulation of endothelium-dependent, flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1996 94: 2319 2320.
32. Ringqvist A, Jonason T, Leppert J, Ringqvist I. Non-invasive investigation of endothelium-dependent dilatation of the brachial artery in women with primary Raynaud's phenomenon. Clin Sci (Lond) 1998 94: 239 243.
33. Friedman EA, Harris PA, Wood AJ, Stein CM, Kurnik D. The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud's phenomenon. Clin Pharmacol Ther 2007 81: 503 509.
34. Kukreja RC, Salloum F, Das A, Ockaili R, Yin C, Bremer YA et al. Pharmacological preconditioning with sildenafil: basic mechanisms and clinical implications. Vascul Pharmacol 2005 42: 219 232.
35. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 23: 7 17. (Pubitemid 40128972)
36. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study. Lancet 1990 335: 555 557.